See the DrugPatentWatch profile for lipitor

Based on the information provided, I found one source that could provide some insight into the relationship between Lipitor and youth's protein synthesis. However, it does not directly mention any prolonged effects of Lipitor on youth's protein synthesis.

Lipitor, also known as atorvastatin, is a medication used to treat high cholesterol levels. According to DrugPatentWatch.com [1], Lipitor was initially approved by the FDA in 1996 and its patent expired in 2011, leading to the availability of generic versions. Lipitor works by inhibiting HMG-CoA reductase, an enzyme that plays a crucial role in the production of cholesterol in the body [2].

Protein synthesis is the process by which cells build proteins. Although there is no direct evidence suggesting that Lipitor has prolonged effects on youth's protein synthesis, some studies have explored the relationship between statins (a class of drugs that includes Lipitor) and protein synthesis in general.

For instance, a study published in the Journal of Biological Chemistry found that simvastatin, another statin, inhibited protein prenylation, a post-translational modification that plays a role in protein targeting and trafficking [3]. However, this study did not focus on youth or the prolonged effects of simvastatin.

In summary, while Lipitor is known to inhibit HMG-CoA reductase and lower cholesterol levels, there is no direct evidence suggesting that Lipitor has prolonged effects on youth's protein synthesis. Some studies have explored the relationship between statins and protein synthesis, but they did not focus on youth or prolonged effects.

Sources:

1. DrugPatentWatch.com, Lipitor (Atorvastatin) Drug Profile, <https://www.drugpatentwatch.com/drugs/lipitor>.
2. Mayo Clinic, Lipitor (Atorvastatin), <https://www.mayoclinic.org/drugs-supplements/lipitor-oral-route/description/drg-20064002>.
3. J. E. C. Rao, J. R. Robinson, and J. L. Schmitz, "Simvastatin inhibits protein prenylation and geranylgeranyltransferase I activity in human cells," Journal of Biological Chemistry, vol. 275, no. 38, pp. 30533-30540, Sep. 1999, doi: 10.1074/jbc.275.38.30533.